# Octapharma Plasma Inc – FDA Inspection, Mar 9, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/695e775e-ac19-4254-9a45-5cf1a52a0fed
Source feed: FDA_Inspections

> FDA inspection 1201064 of Octapharma Plasma Inc, March 09, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201064
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-03-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laressa-r-gray/fba337d5-35df-46fd-92fd-5068ef1c025f)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/4fa5b588-06f2-4b29-9fba-c585ad507ab5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d